Diverging Paths: Major Funds Take Opposing Stositions on Aixtron Ahead of Earnings
08.04.2026 - 04:54:49 | boerse-global.de
Two of the world's most prominent institutional investors have made contrasting moves regarding Aixtron shares, with filings submitted to financial regulators on the same day. Morgan Stanley increased its stake, while BlackRock slightly reduced its holding. This positioning shift comes just before the company's first-quarter report, scheduled for April 30.
Current Operations Contrast with Share Performance
The company's near-term operational outlook remains challenging. For Q1, Aixtron anticipates revenue of approximately €65 million, a figure significantly below the average analyst estimate of €111 million. This shortfall is primarily attributed to its silicon carbide (SiC) segment. An oversupply of silicon carbide equipment is suppressing demand, with a genuine recovery not expected until 2027. The company projects that demand will be reignited by the broader adoption of 800-volt battery systems in electric mobility at that time.
Despite this headwind, the stock has performed strongly, advancing roughly 73% since the start of the year. This rally appears to be pricing in the medium-term investment thesis rather than reflecting the current quarterly performance.
Should investors sell immediately? Or is it worth buying Aixtron?
Strategic Expansion and a Solid Balance Sheet
Aixtron is pursuing a strategic expansion focused on Asia. The company is establishing a new production facility in Malaysia, which will handle assembly, testing, and engineering support for regional customers. An investment of around €40 million is allocated to this project, with initial deliveries planned from late 2027 onward.
Financing this growth is not seen as a constraint. The company boasts an equity ratio of 88% and holds liquid assets of €224.6 million, providing substantial financial flexibility.
Analyst Consensus Highlights Structural Growth Drivers
Several investment banks have recently reaffirmed positive ratings for Aixtron, focusing on long-term growth drivers. Barclays maintains an "Overweight" stance, citing structural growth in gallium nitride power electronics for AI data centers. Morgan Stanley raised its price target to €35 but kept an "Equal-weight" rating. Both JPMorgan and Jefferies confirmed a price target of €36.50.
Key Dates for Investor Focus
Attention now turns to upcoming corporate events. The Q1 order intake figures, to be released on April 30, will indicate whether demand is already supporting the ongoing capacity investments in Asia. The Annual General Meeting follows on May 13. Shareholders will vote on a proposed unchanged dividend of €0.15 per share. The agenda also includes proposals for new financing instruments, such as authorized capital and convertible bonds, which would grant the company greater flexibility for funding future growth initiatives.
Ad
Aixtron Stock: New Analysis - 8 April
Fresh Aixtron information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Diverging Aktien ein!
Für. Immer. Kostenlos.

